BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20724953)

  • 1. Acute disseminated fatal toxoplasmosis after haploidentical stem cell transplantation despite atovaquone prophylaxis in a young man.
    Garcia de la Fuente I; Ansari M; Rougemont AL; Passweg JR; Gumy-Pause F; Ozsahin H; Lobrinus JA; Posfay-Barbe KM
    Pediatr Infect Dis J; 2010 Nov; 29(11):1059-60. PubMed ID: 20724953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation.
    Megged O; Shalit I; Yaniv I; Stein J; Fisher S; Levy I
    Pediatr Transplant; 2008 Dec; 12(8):902-5. PubMed ID: 18194354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Mendorf A; Klyuchnikov E; Langebrake C; Rohde H; Ayuk F; Regier M; Christopeit M; Zabelina T; Bacher A; Stübig T; Wolschke C; Bacher U; Kröger N
    Acta Haematol; 2015; 134(3):146-54. PubMed ID: 25968483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsy.
    Duband S; Cornillon J; Tavernier E; Dumollard JM; Guyotat D; Péoc'h M
    Transpl Infect Dis; 2008 Oct; 10(5):372-4. PubMed ID: 18384483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated toxoplasmosis resulting in graft failure in a cord blood stem cell transplant recipient.
    Goebel WS; Conway JH; Faught P; Vakili ST; Haut PR
    Pediatr Blood Cancer; 2007 Feb; 48(2):222-6. PubMed ID: 16333839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasmosis after allogeneic stem cell transplantation--a single centre experience.
    Busemann C; Ribback S; Zimmermann K; Sailer V; Kiefer T; Schmidt CA; Schulz K; Steinmetz I; Dombrowski F; Dölken G; Krüger WH
    Ann Hematol; 2012 Jul; 91(7):1081-9. PubMed ID: 22249208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous toxoplasmosis after bone marrow transplantation with molecular confirmation.
    Amir G; Salant H; Resnick IB; Karplus R
    J Am Acad Dermatol; 2008 Nov; 59(5):781-4. PubMed ID: 18723241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac toxoplasmosis after heart transplantation diagnosed by endomyocardial biopsy.
    Petty LA; Qamar S; Ananthanarayanan V; Husain AN; Murks C; Potter L; Kim G; Pursell K; Fedson S
    Transpl Infect Dis; 2015 Oct; 17(5):719-22. PubMed ID: 26094707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient.
    Osthoff M; Chew E; Bajel A; Kelsey G; Panek-Hudson Y; Mason K; Szer J; Ritchie D; Slavin M
    Transpl Infect Dis; 2013 Feb; 15(1):E14-9. PubMed ID: 23279790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.
    Chueng TA; Moroz IV; Anderson AD; Morris MI; Komanduri KV; Camargo JF
    Transpl Infect Dis; 2020 Feb; 22(1):e13198. PubMed ID: 31614058
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of intravenous pentamidine prophylaxis to prevent pneumocystis pneumonia in a pediatric hematopoietic stem cell transplant (HSCT) patient.
    Milstone AM; Balakrishnan SL; Foster CB; Chen A
    Pediatr Blood Cancer; 2006 Nov; 47(6):859-60. PubMed ID: 16568443
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling.
    Ikegame K; Tanji Y; Kitai N; Tamaki H; Kawakami M; Fujioka T; Oka Y; Maruya E; Saji H; Sugiyama H; Ogawa H
    Bone Marrow Transplant; 2003 Mar; 31(6):507-10. PubMed ID: 12665848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal obstructive lung disease after haploidentical sibling cord blood transplantation.
    Ohnuma K; Toyoda Y; Ishida Y; Honda K; Nagao T; Ijiri R; Tanaka Y; Goto K; Hiroki K; Kigasawa H; Nishihira H
    Bone Marrow Transplant; 1998 May; 21(9):939-41. PubMed ID: 9613788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation.
    Zeiser R; Grüllich C; Bertz H; Pantazis G; Hufert FT; Bley TA; Finke J
    Bone Marrow Transplant; 2004 Jan; 33(2):243-5. PubMed ID: 14716290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
    Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
    Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Martino R; Bretagne S; Rovira M; Ullmann AJ; Maertens J; Held T; Deconinck E; Cordonnier C
    Bone Marrow Transplant; 2000 May; 25(10):1111-4. PubMed ID: 10828877
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated toxoplasmosis after BMT--report of a case.
    Machado CM; Boas LS; Canto CL; Andrade Júnior HF; Castelli J; Bohringer P; Ostronoff M; Dulley F; Pannuti CS
    Bone Marrow Transplant; 1992 Nov; 10(5):475-8. PubMed ID: 1464016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.